In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia

Has Antifungal Susceptibility Testing Come of Age?

John Rex, Michael A. Pfaller · Clinical Infectious Diseases · 2002 · 363 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +15

Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans

Kenneth J. Tomecki · Journal of the American Academy of Dermatology · 1997 · 239 citations

Life Sciences, Infectious Diseases, Microbiology +12

Trends in Antifungal Drug Susceptibility of <i>Cryptococcus neoformans</i> Isolates in the United States: 1992 to 1994 and 1996 to 1998

Mary E. Brandt, Michael A. Pfaller, Rana Hajjeh et al. · Antimicrobial Agents and Chemotherapy · 2001 · 126 citations

Life Sciences, Infectious Diseases, Microbiology +17

In Vitro Activities of Voriconazole, Fluconazole, and Itraconazole against 566 Clinical Isolates of <i>Cryptococcus neoformans</i> from the United States and Africa

Michael A. Pfaller, J. Zhang, S. A. Messer et al. · Antimicrobial Agents and Chemotherapy · 1999 · 115 citations · Full text

Medicine, Infectious Diseases, Microbiology +13

Detection of Resistance to Amphotericin B among <i>Cryptococcus neoformans</i> Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies

Mario Lozano‐Chiu, Victor L. Paetznick, Mahmoud A. Ghannoum et al. · Journal of Clinical Microbiology · 1998 · 105 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16